Literature DB >> 7783555

Octreotide for protein-losing enteropathy with intestinal lymphangiectasia.

D J Bac, P M Van Hagen, P T Postema, A M ten Bokum, P E Zondervan, M van Blankenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7783555     DOI： 10.1016/s0140-6736(95)90145-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  Primary Intestinal Lymphangiectasia.

Authors:  Charles M. Bliss; Paul C. Schroy III
Journal:  Curr Treat Options Gastroenterol       Date:  2004-02

2.  Type I intestinal lymphangiectasia treated successfully with slow-release octreotide.

Authors:  R D Klingenberg; N Homann; D Ludwig
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

3.  Enteral nutrition as a primary therapy for intestinal lymphangiectasia: value of elemental diet and polymeric diet compared with total parenteral nutrition.

Authors:  Kunihiko Aoyagi; Mitsuo Iida; Takayuki Matsumoto; Shotaro Sakisaka
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

4.  Octreotide for treating chylothorax after cardiac surgery.

Authors:  Dalokay Kilic; Ekber Sahin; Oner Gulcan; Bulent Bolat; Riza Turkoz; Ahmet Hatipoglu
Journal:  Tex Heart Inst J       Date:  2005

5.  Chylothorax after thoracoscopic extended thymectomy: a case report and literatures review.

Authors:  Zhirong Zhang; Xiaoxing Hu; Qirui Chen; Hui Li
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

6.  Protein-Losing Enteropathy and Gastropathy.

Authors:  Brian R. Landzberg; Mark B. Pochapin
Journal:  Curr Treat Options Gastroenterol       Date:  2001-02

7.  Chylothorax after blunt trauma.

Authors:  Eric Seitelman; Jason J Arellano; Kazuaki Takabe; Leonard Barrett; Glenn Faust; L D George Angus
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

8.  [Chronic diarrhea in a 43-year-old patient].

Authors:  J Strehl; M Schepke; E Wardelmann; W H Caselmann; T Sauerbruch
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

9.  Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia.

Authors:  Siham Al Sinani; Yusria Al Rawahi; Hamed Abdoon
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

10.  Successful treatment of protein-losing enteropathy induced by intestinal lymphangiectasia in a liver cirrhosis patient with octreotide: a case report.

Authors:  Hang Lak Lee; Dong Soo Han; Jin Bae Kim; Yong Chul Jeon; Joo Hyun Sohn; Joon Soo Hahm
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.